rs776570317
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001145809.2(MYH14):c.3571G>T(p.Ala1191Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000618 in 1,457,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145809.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 4AInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- peripheral neuropathy-myopathy-hoarseness-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH14 | NM_001145809.2 | c.3571G>T | p.Ala1191Ser | missense_variant | Exon 28 of 43 | ENST00000642316.2 | NP_001139281.1 | |
| MYH14 | NM_001077186.2 | c.3472G>T | p.Ala1158Ser | missense_variant | Exon 27 of 42 | NP_001070654.1 | ||
| MYH14 | NM_024729.4 | c.3448G>T | p.Ala1150Ser | missense_variant | Exon 26 of 41 | NP_079005.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH14 | ENST00000642316.2 | c.3571G>T | p.Ala1191Ser | missense_variant | Exon 28 of 43 | NM_001145809.2 | ENSP00000493594.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000618 AC: 9AN: 1457270Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724562 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Ala1191Ser va riant in MYH14 has not been previously reported in individuals with hearing loss , but has been identified in 1/44386 of European chromosomes by the Exome Aggreg ation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs776570317). Alth ough this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Alanine (Ala) at position 1191 is not conserved in mammals or evolutionarily distant species and 9 species (Opossum, white-throated sparrow, medium ground finch, zebra finch, tibetan ground jay, tu rkey, X tropicalis, tetraodon and lamprey) carry a serine (Ser) at this position , raising the possibility that this change may be tolerated. Additional computat ional prediction tools suggest that the p.Ala1191Ser variant may impact the prot ein, though this information is not predictive enough to determine pathogenicity . In summary, while the clinical significance of the p.Ala1191Ser variant is unc ertain, its presence in various species suggests that it is more likely to be be nign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at